ALNY Competitors & Alternatives
Compare Alnylam Pharmaceuticals Inc with similar stocks in the same industry
Biotechnology
ALNY
Main Stock$224.03
Tradestie Score
52
Market Cap
$60.38B
P/E Ratio
38.3
Revenue Growth
0.7%
Analyst Upside
+64.6%
Top Competitors
218 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
ARGX
argenx SE American Depositary Shares
|
$873.71
|
$46.96B | 30.3 | 52 | Compare |
|
ONC
BeOne Medicines Ltd. American Depositary Shares
|
$377.63
|
$36.81B | 69.1 | 38 | Compare |
|
INSM
Insmed, Inc.
|
$93.39
|
$31.13B | - | 53 | Compare |
|
BNTX
BioNTech SE American Depositary Share
|
$88.12
|
$24.57B | - | 53 | Compare |
|
GMAB
Genmab A/S ADS
|
$43.79
|
$19.56B | 31.3 | 41 | Compare |
|
INCY
Incyte Genomics Inc
|
$115.71
|
$16.93B | 14.9 | 69 | Compare |
|
RPRX
Royalty Pharma plc Class A Ordinary Shares
|
$63.86
|
$15.70B | 33.9 | 49 | Compare |
|
SMMT
Summit Therapeutics Inc. Common Stock
|
$15.47
|
$15.22B | - | 52 | Compare |
|
NBIX
Neurocrine Biosciences Inc
|
$142.70
|
$13.59B | 20.7 | 56 | Compare |
|
ASND
Ascendis Pharma A/S American Depositary Shares
|
$243.37
|
$12.36B | 18.3 | 51 | Compare |
More ALNY Analysis
Data updated: Oct 24, 2026 | Industry: Biotechnology (SIC 2834)
218 stocks in this industry